Lactose intolerance – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 05 Jun 2026 10:54:19 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Lactose intolerance – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness of Gaxilose for Diagnosing Lactose Intolerance in Children Aged 5 to 11 Years https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-gaxilose-for-diagnosing-lactose-intolerance-in-children-aged-5-to-11-years/ Wed, 29 Apr 2026 15:06:00 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-gaxilose-for-diagnosing-lactose-intolerance-in-children-aged-5-to-11-years/ This clinical trial is focused on studying lactose intolerance in children aged 5 to 11 years. Lactose intolerance is a condition where the body has difficulty digesting lactose, a sugar found in milk and dairy products. The study will use a treatment called LacTEST, which contains the active substance gaxilose. LacTEST is an oral solution designed to help diagnose a specific type of lactose intolerance known as hypolactasia, where the body produces low levels of the enzyme needed to break down lactose.

The purpose of the study is to evaluate how well LacTEST works in diagnosing hypolactasia in children who show symptoms of lactose intolerance. During the study, children will take LacTEST, and their urine will be collected over a period of time to measure the amount of a substance called xylose. This measurement will help determine if the child has hypolactasia or not. The study aims to confirm if a specific amount of xylose in the urine can accurately classify children as having hypolactasia or not, based on standard clinical practices.

The study will also explore different ways to improve the test, such as using different amounts of xylose or shortening the urine collection time. Additionally, the study will monitor any side effects that may occur in children taking LacTEST. The goal is to ensure that LacTEST is a reliable and safe method for diagnosing lactose intolerance in children.

]]> Study on Gaxilose for Diagnosing Lactose Intolerance in Children Aged 5-11 https://clinicaltrials.eu/trial/study-on-gaxilose-for-diagnosing-lactose-intolerance-in-children-aged-5-11/ Wed, 29 Apr 2026 15:05:37 +0000 https://clinicaltrials.eu/trial/study-on-gaxilose-for-diagnosing-lactose-intolerance-in-children-aged-5-11/ This clinical trial is focused on studying a condition known as hypolactasia, which is a reduced ability to digest lactose, a sugar found in milk and dairy products. The trial will use a treatment called Gaxilose, which is administered as an oral solution known as LacTEST. The purpose of the study is to determine a specific level of a substance called xylose in urine that can help diagnose hypolactasia in children aged 5 to 11 years.

During the study, participants will receive a single dose of Gaxilose. The trial is designed to be double-blind and randomized, meaning neither the participants nor the researchers will know who is receiving the actual treatment or a placebo. The study will monitor the amount of xylose excreted in the urine over a few hours after taking the dose. This will help establish a cut-off point for diagnosing hypolactasia.

In addition to measuring urinary xylose levels, the study will also observe any side effects or changes in health indicators, such as laboratory test results and vital signs, in participants who receive Gaxilose compared to those who receive a placebo. The trial aims to ensure the safety and effectiveness of using Gaxilose for diagnosing hypolactasia in children.

]]>